在膀癌患者的外科手术期间使用Enfortumab Vedotin和Pembrolizumab
Christof Vulsteke1,2, Nabil Adra3, Pongwut Danchaivijitr4
1Integrated Cancer Center Ghent, AZ Maria Middelares, Ghent, Belgium.
The New England journal of medicine
|February 18, 2026
概括
术后安福图马布 (vedotin) 加上潘布罗利祖马布 ( pembrolizumab) 显著改善了肌肉侵入性膀癌患者的无事件和整体存活率,这些患者不符合西斯普拉丁化疗的条件. 与单独手术相比,这种联合治疗也增加了病理完整反应率.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 癌症治疗方法 癌症治疗方法
背景情况:
- 肌肉侵入性膀癌 (MIBC) 患者无法接受西斯普拉丁化疗通常会接受激进囊切除术.
- 周围手术治疗提供了一个潜在的策略,以提高这一特定患者群体的结果.
研究的目的:
- 为了评估术后安福图马布 (enfortumab) 韦多加布罗利祖马布 ( pembrolizumab) 结合手术的疗效和安全性,在不接受西斯普拉丁治疗的MIBC患者中.
- 为了比较无事件生存率,总生存率和病理完整反应率与单独的手术.
主要方法:
- 第3期,开放标签,随机试验,涉及不接受西斯的MIBC患者.
- 参与者接受了外科手术前的Enfortumab vedotin加上Pembrolizumab和手术或单独手术.
- 主要终点是无事件生存;次要终点包括整体生存和病理完整反应.
主要成果:
- 经外科手术后的恩福图马布 (enfortumab) 韦多丁加上潘布罗利祖马布 ( pembrolizumab) 显著改善了两年无事件存活率 (74.7% vs 39.4%) 和整体存活率 (79.7% vs 63.1%).
- 综合疗法组的病理完整响应率明显高于组合疗法组 (57.1%对比8.6%).
- 在组合手臂的所有参与者中观察到不良事件,其中71.3%发生了≥3级事件.
结论:
- 术后安福图马布 (vedotin) 加上潘布罗利祖马布 ( pembrolizumab) 提供了显著的生存益处和更高的病理完整响应率,适用于西斯普拉丁不合格的MIBC患者.
- 组合疗法对这一群体来说是一个有前途的治疗方法,尽管安全考虑很重要.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Urinary Tract Calculi VI: Surgical Management
616
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
616
Urinary Bladder
3.7K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.7K
Urinary Tract Calculi III: Medical Management
288
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
288


